Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 4Q21 and 2021 Net Income per Share – Diluted of $0.47 and $3.82, respectively; 4Q21 and 2021 FFO per Share

Key highlights

Operating results

4Q21

4Q20

2021

2020

Total revenues:

In millions

$  576.9

$     463.7

$  2,114.2

$  1,885.6

Growth

24.4%

12.1%

Net income attributable to Alexandria’s common stockholders – diluted

In millions

$    72.8

$     435.9

$     563.4

$     760.8

Per share

$    0.47

$       3.26

$       3.82

$       6.01

Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted

In millions

$  303.6

$     246.6

$  1,144.9

$     923.8

Per share

$    1.97

$       1.84

$       7.76

$       7.30